Sacubitril/valsartan
Who holds supplier records for Sacubitril/valsartan? 23 organisations hold a current record for Sacubitril/valsartan: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (12), China (10) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Sacubitril/valsartan: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/sacubitril-valsartan
Reading the evidence
- 23 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (23)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sacubitril/valsartan. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 39628, 40981 · latest filing Dec 2024
- CHANGZHOU PHARMACEUTICAL FACTORYChina Company GMP cert on recordActive DMF 35480, 43974 · latest filing Apr 2026
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 33657, 42543 · latest filing Sept 2025
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 41246, 39023 · latest filing Feb 2025
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 33570 · latest filing Mar 2019
- AMI LIFESCIENCES PRIVATE LTDIndia Company GMP cert on recordActive DMF 37994 · latest filing Mar 2023
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaActive DMF 39929 · latest filing Jun 2024
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 31574 · latest filing Aug 2017
- Exemed PharmaceuticalsIndia Company GMP cert on recordActive DMF 41944 · latest filing May 2025
- GANSU HAOTIAN PHARMA TECH CO LTDChinaActive DMF 40549 · latest filing Sept 2024
- HARMAN FINOCHEM LTDIndia Company GMP cert on recordActive DMF 33452 · latest filing Feb 2019
- Jiangsu Lianhuan Pharmaceutical Co.,Ltd.ChinaActive DMF 39591 · latest filing Feb 2024
- LINHAI TIANYU PHARMACEUTICAL CO LTDChinaActive DMF 39382 · latest filing Jan 2024
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 33455 · latest filing Jan 2019
- Mankind Pharma LimitedIndia Company GMP cert on recordActive DMF 36637 · latest filing Jan 2022
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 32254 · latest filing Dec 2017
- Sichuan Kelun Pharmaceutical Co., Ltd.ChinaActive DMF 41409 · latest filing Feb 2025
- TAPI NL BVNetherlandsActive DMF 33457 · latest filing Feb 2019
- Wisdom Pharmaceutical Co., LtdChinaActive DMF 39322 · latest filing Dec 2023
- Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.ChinaActive DMF 42857 · latest filing Oct 2025
- Zhejiang Huahai Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 40137 · latest filing Jul 2024
- Zhejiang Raybow Pharmaceutical Co.,Ltd.China Company GMP cert on recordActive DMF 40710 · latest filing Sept 2025
- ZHUHAI RUNDU PHARMACEUTICAL CO LTDChinaActive DMF 35868 · latest filing Apr 2021
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Overview
Sacubitril/Valsartan is a combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker, used to reduce the risk of cardiovascular death and hospitalization for heart failure patients with reduced ejection fraction. This combination enhances the protective neurohormonal systems of the heart while suppressing the harmful systems, promoting vasodilation and blood pressure reduction.
Chemical identity
- IUPAC name
- 4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid;(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
- Canonical SMILES
- CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O.CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O
- InChIKey
- XTKIDERFOUYBDE-QEPKIHTBSA-N
- Synonyms
- Calquence API, lcz-696 free acid, sacubitril valsartan
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin 2 Receptor Blocker
- Mechanism of action
- Angiotensin 2 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sacubitril/valsartan?
23 organisations hold an active US FDA Type II Drug Master File or a CEP for Sacubitril/valsartan: AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India), CHANGZHOU PHARMACEUTICAL FACTORY (China), HONOUR LAB LTD (India), LEE PHARMA LTD (India), Alembic Pharmaceuticals Limited (India), AMI LIFESCIENCES PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India) and Dr. Reddy's Laboratories Ltd. (India), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Sacubitril/valsartan Drug Master Files are active?
AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 39628, 40981), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 35480, 43974), HONOUR LAB LTD (DMF 33657, 42543), LEE PHARMA LTD (DMF 41246, 39023), Alembic Pharmaceuticals Limited (DMF 33570), AMI LIFESCIENCES PRIVATE LTD (DMF 37994), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 39929) and Dr. Reddy's Laboratories Ltd. (DMF 31574) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Sacubitril/valsartan supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sacubitril/valsartan?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.